Fibrolamellar hepatocellular carcinoma imaging is a type of imaging used to diagnose fibrolamellar hepatocellular carcinoma (FL-HCC), a rare form of liver cancer. This type of imaging typically includes computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and ultrasound scans. These imaging techniques can help doctors to identify the size and location of the tumor, as well as any other abnormalities in the liver.

1. Abdominal pain
2. Abdominal swelling
3. Unexplained weight loss
4. Loss of appetite
5. Nausea and vomiting
6. Jaundice (yellowing of the skin and eyes)
7. Enlarged liver
8. Enlarged spleen
9. Abnormal liver function tests
10. Abnormal imaging findings on CT or MRI scans, such as a mass or nodule in the liver

1. Genetic mutations: Fibrolamellar hepatocellular carcinoma (FL-HCC) is caused by a mutation in the PRKACA gene. This gene is responsible for producing a protein called protein kinase A, which helps regulate cell growth and division.

2. Environmental factors: Exposure to certain environmental toxins, such as aflatoxins, may increase the risk of developing FL-HCC.

3. Viral infections: Certain viral infections, such as hepatitis B and C, may increase the risk of developing FL-HCC.

4. Family history: Having a family history of FL-HCC may increase the risk of developing the disease.

1. Surgery: Surgery is the primary treatment for Fibrolamellar Hepatocellular Carcinoma (FL-HCC). The goal of surgery is to remove the tumor and any surrounding tissue that may be affected.

2. Radiation Therapy: Radiation therapy may be used to shrink the tumor before or after surgery.

3. Chemotherapy: Chemotherapy may be used to shrink the tumor before or after surgery.

4. Targeted Therapy: Targeted therapy is a type of treatment that uses drugs to target specific molecules involved in the growth and spread of cancer cells.

5. Immunotherapy: Immunotherapy is a type of treatment that uses the body’s own immune system to fight cancer.

6. Clinical Trials: Clinical trials are research studies that test new treatments for FL-HCC.

1. Exposure to aflatoxins
2. Family history of the disease
3. Genetic mutations in the HNF1A gene
4. Chronic liver disease
5. Cirrhosis
6. Non-alcoholic fatty liver disease
7. Exposure to certain chemicals
8. Obesity
9. Type 2 diabetes
10. Male gender
11. Age (typically between 15 and 30 years old)

There is no cure for Fibrolamellar Hepatocellular Carcinoma (FL-HCC). However, there are treatments available to help manage the disease. These include surgery, chemotherapy, radiation therapy, and targeted therapy. Imaging tests such as CT scans, MRI scans, and PET scans are used to help diagnose and monitor the disease.